-
JCAHO posts 2005 National Patient Safety Goals; ISDA appeals to lawmakers for antibiotic development; HHS gives details of Medicare reform proposal; FDA establishes new cancer office, program.
-
Two studies published in the July 29 issue of the New England Journal of Medicine have found high efficacy rates among patients coinfected with chronic hepatitis C virus (HCV) and HIV who were treated with pegylated interferon and ribavirin.
-
Health care providers now have another choice of cholesterol-lowering treatments. The FDA recently approved the combination of two cholesterol drugs, ezetimibe (Zetia) and simvastatin (Zocor), into a single pill. The product is being marketed under the name Vytorin. It is administered as a once-daily tablet and should be taken in the evening with or without food.
-
The National Cholesterol Education Programs (NCEP) clinical practice guidelines on cholesterol management have been updated to set even lower treatment goals for low-density lipoprotein (LDL) cholesterol for patients at high and moderately high risk for a heart attack. The guidelines, for example, offer a new therapeutic option for very high-risk patients to achieve levels of less than 70 mg/dL.
-
-
You dont always know which experiences might prove beneficial when it comes to building a successful career in access services.
-
A new registration report card at Childrens Health Care of Atlanta provides access managers with key information on the performance of individual employees in a convenient, easy to read format.
-
Higher patient copays and increasing numbers of people who are working but not insured have made the management of self-pay accounts a more crucial issue than ever for most of the nations hospitals.
-
-
This article points out the disadvantages of partial DNR ordersfor both clinicians and patientsand offers clear steps for mitigating the problem by developing a supplemental patient care plan for patients who are less than full code.
